Hjem › Multipel sklerose › Kentucky
Multipel sklerose kliniske forsøg i Kentucky
3 studier for Multipel sklerose søger deltagere på steder i Kentucky.
Officiel studietekst (engelsk)
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
- University of Kentucky/Markey Cancer Center, Lexington
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 23. sep. 2026 · NCT03816345A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)
- TG Therapeutics Investigational Trial Site, Lexington
- TG Therapeutics Investigational Trial Site, Louisville
RekruttererObservationsstudie
Alder 18 og opefter · Alle køn · Opdateret 23. sep. 2026 · NCT06433752Study to Evaluate the Effectiveness and Safety of Ozanimod Compared to Fingolimod in Children and Adolescents With Relapsing Remitting Multiple Sclerosis
- University of Louisville, Norton Children's Research Institute, Louisville
RekruttererFase 3
Alder 10 til 17 · Alle køn · Opdateret 10. sep. 2026 · NCT06408259Fra ClinicalTrials.gov, data hentet 3. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.